CAS RN: 464192-28-7
2-Bromo-5-fomylthiazole
Product Availability
Choose a grade to view its available package options.
5 package records5 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250317 |
100g |
In stock |
| | Inquiry |
| Batchno.20250608 |
1g |
In stock |
| | Inquiry |
| Batchno.20260613 |
25g |
In stock |
| | Inquiry |
| Batchno.20250625 |
5g |
In stock |
| | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260625 |
1g / 5g / 25g |
Confirm by inquiry |
Shandong | 5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 5g, 10g, 1g, 25g, 100g
- Available purity: >97%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 464192-28-7
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 5g |
>97% |
5
In Stock
|
Beijing |
Inquiry |
| 10g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 1g |
>97% |
2
In Stock
|
Hong Kong |
Inquiry |
| 25g |
>97% |
1
In Stock
|
Shanghai |
Inquiry |
| 100g |
>97% |
0
Out of Stock
|
Shanghai |
Inquiry |
464192-28-7 / 4-bromo-1,3-thiazole-2-carbaldehyde
Standard CAS: 464192-28-7
Multi CAS: Yes
Basic Information
CAS
464192-28-7
Multi CAS
Yes
Molecular Formula
BC4H2ORnS
Molecular Weight
192.040000
Exact Mass
190.904050
InChI
InChI=1S/C4H2BrNOS/c5-4-6-1-3(2-7)8-4/h1-2H
InChIKey
DJUWIZUEHXRECB-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
8
Aromatic heavy atom count
5
Rotatable bonds
1
H-bond acceptors
3
Molar refractivity
35.2
TPSA
29.96
LogP / Solubility
WLOGP
1.72
MLOGP
1.51
XLogP3
1.8
Consensus LogP
1.68
Log S (ESOL)
-2.51
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.38
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.45
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.67
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5